Torthaí cuardaigh - Yoshiko Takeda‐Uchimura
- 1 - 2 toradh as 2 á dtaispeáint
-
1
Deficiency of a sulfotransferase for sialic acid-modified glycans mitigates Alzheimer’s pathology de réir Zui Zhang, Yoshiko Takeda‐Uchimura, Tahmina Foyez, Shiori Ohtake‐Niimi, Narentuya, Hiroyasu Akatsu, Kazuchika Nishitsuji, Makoto Michikawa, Tony Wyss‐Coray, Kenji Kadomatsu, Kenji Uchimura
Foilsithe / Cruthaithe 2017Artigo -
2
Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease de réir Markus Britschgi, Christopher E. Olin, Hudson Johns, Yoshiko Takeda‐Uchimura, Melburne C. LeMieux, Kaspar Rufibach, Jayakumar Rajadas, H. Zhang, Beren H. Tomooka, William H. Robinson, Christopher M. Clark, Anne M. Fagan, Douglas Galasko, David M. Holtzman, Marek Jutel, Jeffrey Kaye, Cynthia A. Lemere, Jerzy Leszek, G. Li, Elaine R. Peskind, Joseph F. Quinn, Jerome A. Yesavage, Jorge Ghiso, Tony Wyss‐Coray
Foilsithe / Cruthaithe 2009Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Alzheimer's disease
Amyloid (mycology)
Biochemistry
Biology
Chemistry
Disease
Immunology
Medicine
Pathology
Amyloid precursor protein
Antibody
Cerebrospinal fluid
Environmental health
Extracellular matrix
Glycan
Glycoprotein
Inflammation
Inorganic chemistry
Internal medicine
Keratan sulfate
Microglia
Neuroprotection
Peptide
Pharmacology
Population
Proteoglycan
Receptor
SIGLEC
Sialic acid
TREM2